This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Naoshi Horiba: Innovator in Pharmaceutical Development
Introduction
Naoshi Horiba is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating various medical conditions.
Latest Patents
Horiba holds a patent for a dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same. This invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt. It includes a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification. The compound serves as an active ingredient, along with a method for prevention and/or treatment.
Career Highlights
Horiba is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work has been instrumental in advancing the company's research and development efforts in innovative drug therapies.
Collaborations
Throughout his career, Horiba has collaborated with notable colleagues, including Yoshihito Ohtake and Naoki Okamoto. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Naoshi Horiba's contributions to pharmaceutical innovation exemplify the impact of dedicated inventors in the medical field. His work continues to pave the way for advancements in treatment options for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
